Jared Knopman, MD
New York-Presbyterian Hospital/Weill Cornell Medicine and Memorial Sloan-Kettering Cancer Hospital as Chief Resident
Mount Sinai School of Medicine
Jared Knopman, MD, is a board-certified neurosurgeon and interventional neuroradiologist who specializes in cerebrovascular disorders, aneurysms, AVM’s, brain tumors, and carotid occlusive disease. He has expertise in embolization of aneurysms and AVM’s, carotid stenting/endarterectomy, and intra-arterial chemotherapy. He also performs spinal cord stimulation and microvascular decompression for chronic pain syndromes and trigeminal neuralgia. He is one of the few neurosurgeons in NYC with dual expertise in both open neurosurgical as well as minimally invasive interventional techniques for the treatment of neurologic disease. He is named on the SuperDoctors Rising Stars list, a distinction afforded the top 2.5% of physicians in his field.
Dr. Knopman received a BA.with honors from Northwestern University. He received his M.D. from Mount Sinai School of Medicine. Dr. Knopman completed his surgical internship and neurosurgical residency, serving as chief resident, at NewYork-Presbyterian Hospital/Weill Cornell Medicine and Memorial Sloan-Kettering Cancer Hospital.
Dr. Knopman was one of the original authors of a novel trial of super-selective treatment of malignant brain tumors using targeted chemotherapy, as featured in The New York Times, and he has expanded this technique to children. He lectures both nationally and internationally and was awarded the prestigious CNS/Micrus Endovascular Neurosurgery grant as well as the Leonard and Fleur Harlan Clinical Scholarship for his research in vascular disease. In addition, he is the Principal Investigator at Weill Cornell of an NIH-funded study utilizing topical antibiotics to lower the risk of infection after brain surgery. This is the only such trial occurring in the country.